A recent large, long-term study has shown that people with high blood pressure want to prevent heart attacks, while taking antihypertensive drugs and statins (drugs that help regulate cholesterol levels) may be the best option.

    This study was published on The Lancet Journal under the title "Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up Results of a randomised factorial trial".

    In the new study, the researchers tracked 8,580 British subjects enrolled between 1998 and 2000, all of whom had high blood pressure.

    According to ASCOT data, hypertensive patients who took amlodipine and perindopril for 5.5 years had a 29% reduction in the likelihood of death from a stroke 10 years later than those who received traditional antihypertensive medication.

    Moreover, compared with patients taking placebo alone, statins were taken at a normal level (6.5 mM per liter) of hypertensive patients, and the risk of death from heart disease and stroke was reduced by 15% after 16 years.

    In addition, patients with “double high” were treated with antihypertensive therapy (amlodipine and perindopril) and conventional cholesterol-lowering therapy, and the likelihood of death from cardiovascular disease was reduced by 21% within 10 years.